Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
NUNuwellis, Inc. logo

Nuwellis, Inc. (NUWE)

NASDAQ · Currency in USD
$0.32 ▼ -0.17 (-33.97%)
At close: Oct 23, 4:00 PM ET. Market closed.
$0.34 ▲ +0.02 (+5.62%)
After hours: Oct 23, 7:57 PM ET

Summary

Previous Close
$0.49
Open
$0.47
Day's Range
$0.32 – $0.49
52 Week Range
$0.32 – $172.90
Volume
1,194,216
Avg. Volume
3,095,630
Market Cap
$29.70K
Beta (5Y Monthly)
0.29
PE Ratio (TTM)
--
EPS (TTM)
-$61.35
Earnings Date
Nov 11, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Nuwellis, Inc.

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
38
CEO
Michael McCormick

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021.

Earnings

Next report: Wed, Nov 11, 2026
EPS estimate -$13.65 · Revenue est. $2.51M
DateEst.Actual
Aug 13, 2026-$23.80-$26.64Miss
May 12, 2026-$0.35-$0.73Miss
Mar 10, 2026-$0.55-$0.52Beat
Nov 12, 2025-$602.70$19.58Beat
Aug 14, 2025-$6.62-$21.35Miss
May 13, 2025-$6.61-$10.14Miss

Analyst view

Rating: Buy
Buy 50% · Hold 50% · Sell 0%

Get free alerts on NUWE and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.